Therapeutic targets in Alzheimer's disease and related tauopathies

Progress in Molecular Biology and Translational Science

Volumn 98, Issue C, 2011, Pages 47-83

  Corbo, Christopher P ^a   Alonso, Alejandra Del C ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Amyloid; Hyperphosphorylation; Kinases; MAPs; Microtubules; PHF; Phosphatases; Plaques; Tangles; Tau

Indexed keywords

EID: 78650910921     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385506-0.00002-8     Document Type: Chapter

References (214)

1. G.B. Frisoni, M. Pievani, C. Testa, F. Sabattoli, L. Bresciani, and M. Bonetti The topography of grey matter involvement in early and late onset Alzheimer's disease Brain 130 2007 720 730
2. G. Perry, J. Avila, and J. Kinoshita Alzheimer's disease : a century of scientific and clinical research 2006 IOS Press Amsterdam, NLD
3. M. Kidd Paired helical filaments in electron microscopy of Alzheimer's disease Nature 197 1963 192 193
4. W.J. Strittmatter, A.M. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, and G.S. Salvesen Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease Proc Natl Acad Sci USA 90 1993 1977 1981
5. A. Goate, M.C. Chartier-Harlin, M. Mullan, J. Brown, F. Crawford, and L. Fidani Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease Nature 349 1991 704 706 (Pubitemid 21912142)
6. R. Sherrington, E.I. Rogaev, Y. Liang, E.A. Rogaeva, G. Levesque, and M. Ikeda Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease Nature 375 1995 754 760
7. E. Levy-Lahad, W. Wasco, P. Poorkaj, D.M. Romano, J. Oshima, and W.H. Pettingell Candidate gene for the chromosome 1 familial Alzheimer's disease locus Science (New York, NY) 269 1995 973 977
8. D. Blacker, and R.E. Tanzi The genetics of Alzheimer disease: current status and future prospects Arch Neurol 55 1998 294 296
9. M.A. Pericak-Vance, J. Grubber, L.R. Bailey, D. Hedges, S. West, and L. Santoro Identification of novel genes in Late-onset Alzheimer's disease Exp Gerontol 35 2000 1343 1352
10. F. Amenta, L. Parnetti, V. Gallai, and A. Wallin Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches? Mech Ageing Dev 122 2001 2025 2040
11. P.R. Turner, K. O'Connor, W.P. Tate, and W.C. Abraham Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory Prog Neurobiol 70 2003 1 32
12. L. De Kimpe, and W. Scheper From alpha to omega with Abeta: targeting the multiple molecular appearances of the pathogenic peptide in Alzheimer's disease Curr Med Chem 17 2009 198 212
13. A. Salminen, A. Kauppinen, T. Suuronen, K. Kaarniranta, and J. Ojala ER stress in Alzheimer's disease: a novel neuronal trigger for inflammation and Alzheimer's pathology J Neuroinflammation 6 2009 41
14. I. Grundke-Iqbal, K. Iqbal, Y.C. Tung, M. Quinlan, H.M. Wisniewski, and L.I. Binder Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology Proc Natl Acad Sci USA 83 1986 4913 4917
15. S. Feuillette, L. Miguel, T. Frbourg, D. Campion, and M. Lecourtois Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein J Neurochem 113 2010 895 903
16. C.Y. Ewald, and C. Li Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system Brain Struct Funct 214 2010 263 283
17. W. Xia Exploring Alzheimer's disease in zebrafish J Alzheimer's Dis 20 2010 981 990
18. J. Wang, Y.C. Tung, Y. Wang, X.T. Li, K. Iqbal, and I. Grundke-Iqbal Hyperphosphorylation and accumulation of neurofilament proteins in Alzheimer disease brain and in okadaic acid-treated SY5Y cells FEBS Lett 507 2001 81 87
19. J. Gotz, and N.N. Gotz Animal models for Alzheimer's disease and frontotemporal dementia: a perspective ASN Neuro 1 2009 251 264
20. M. Ramsden, L. Kotilinek, C. Forster, J. Paulson, E. McGowan, and K. SantaCruz Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L) J Neurosci 25 2005 10637 10647
21. A.D. Alonso, J. Diclerico, B. Li, C.P. Corbo, M.E. Alaniz, and I. Grundke-Iqbal Phosphorylation of tau at Thr212, Thr231 and Ser262 combined and not individually causes neurodegeneration J Biol Chem 285 2010 30851 30860
22. M.L. Steinhilb, D. Dias-Santagata, T.A. Fulga, D.L. Felch, and M.B. Feany Tau phosphorylation sites work in concert to promote neurotoxicity in vivo Mol Biol Cell 18 2007 5060 5068
23. L.J. Thal Prevention of Alzheimer disease Alzheimer Dis Assoc Disord 20 2006 S97 S99
24. K. Iqbal, M. Flory, S. Khatoon, H. Soininen, T. Pirttila, and M. Lehtovirta Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers Ann Neurol 58 2005 748 757
25. D. Schenk, R. Barbour, W. Dunn, G. Gordon, H. Grajeda, and T. Guido Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 1999 173 177
26. R. Dodel, F. Neff, C. Noelker, R. Pul, Y. Du, and M. Bacher Intravenous immunoglobulins as a treatment for Alzheimer's disease: rationale and current evidence Drugs 70 2010 513 528
27. F. Bard, C. Cannon, R. Barbour, R.L. Burke, D. Games, and H. Grajeda Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease Nat Med 6 2000 916 919
28. P. Das, V. Howard, N. Loosbrock, D. Dickson, M.P. Murphy, and T.E. Golde Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-/- knock-out mice J Neurosci 23 2003 8532 8538
29. H. Taguchi, S. Planque, Y. Nishiyama, J. Symersky, S. Boivin, and P. Szabo Autoantibody-catalyzed hydrolysis of amyloid beta peptide J Biol Chem 283 2008 4714 4722
30. B.J. Bacskai, S.T. Kajdasz, R.H. Christie, C. Carter, D. Games, and P. Seubert Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy Nat Med 7 2001 369 372
31. P. Seubert, T. Oltersdorf, M.G. Lee, R. Barbour, C. Blomquist, and D.L. Davis Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide Nature 361 1993 260 263
32. B. De Strooper, R. Vassar, and T. Golde The secretases: enzymes with therapeutic potential in Alzheimer disease Nat Rev Neurol 6 2010 99 107
33. C. Haass, and D.J. Selkoe Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide Cell 75 1993 1039 1042
34. D. Hartmann, B. de Strooper, L. Serneels, K. Craessaerts, A. Herreman, and W. Annaert The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts Hum Mol Genet 11 2002 2615 2624
35. T. Maretzky, K. Reiss, A. Ludwig, J. Buchholz, F. Scholz, and E. Proksch ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation Proc Natl Acad Sci USA 102 2005 9182 9187
36. R. Vassar, B.D. Bennett, S. Babu-Khan, S. Kahn, E.A. Mendiaz, and P. Denis Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE Science (New York, NY) 286 1999 735 741
37. H. Cai, Y. Wang, D. McCarthy, H. Wen, D.R. Borchelt, and D.L. Price BACE1 is the major beta-secretase for generation of Abeta peptides by neurons Nat Neurosci 4 2001 233 234
38. Y. Luo, B. Bolon, S. Kahn, B.D. Bennett, S. Babu-Khan, and P. Denis Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation Nat Neurosci 4 2001 231 232
39. N. Takasugi, T. Tomita, I. Hayashi, M. Tsuruoka, M. Niimura, and Y. Takahashi The role of presenilin cofactors in the gamma-secretase complex Nature 422 2003 438 441
40. L. Serneels, J. Van Biervliet, K. Craessaerts, T. Dejaegere, K. Horr, and T. Van Houtvin gamma-Secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer's disease Science (New York, NY) 324 2009 639 642
41. C. Bancher, C. Brunner, H. Lassmann, H. Budka, K. Jellinger, and G. Wiche Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease Brain Res 477 1989 90 99
42. D.A. Koolen, L.E. Vissers, R. Pfundt, N. de Leeuw, S.J. Knight, and R. Regan A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism Nat Genet 38 2006 999 1001
43. C. Shaw-Smith, A.M. Pittman, L. Willatt, H. Martin, L. Rickman, and S. Gribble Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability Nat Genet 38 2006 1032 1037
44. M.C. Varela, A.C. Krepischi-Santos, J.A. Paz, J. Knijnenburg, K. Szuhai, and C. Rosenberg A 17q21.31 microdeletion encompassing the MAPT gene in a mentally impaired patient Cytogenet Genome Res 114 2006 89 92
45. R. Brandt, J. Lger, and G. Lee Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain J Cell Biol 131 1995 1327 1340
46. A. Rendon, D. Jung, and V. Jancsik Interaction of microtubules and microtubule-associated proteins (MAPs) with rat brain mitochondria Biochem J 269 1990 555 556
47. Q. Hua, R.Q. He, N. Haque, M.H. Qu, A. del Carmen Alonso, and I. Grundke-Iqbal Microtubule associated protein tau binds to double-stranded but not single-stranded DNA Cell Mol Life Sci 60 2003 413 421
48. T. Kampers, P. Friedhoff, J. Biernat, E.M. Mandelkow, and E. Mandelkow RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments FEBS Lett 399 1996 344 349
49. R. Dixit, J.L. Ross, Y.E. Goldman, and E.L.F. Holzbaur Differential regulation of dynein and kinesin motor proteins by tau Science (New York, NY) 319 2008 1086 1089
50. M. DiTella, F. Feiguin, G. Morfini, and A. Cceres Microfilament- associated growth cone component depends upon Tau for its intracellular localization Cell Motil Cytoskeleton 29 1994 117 130
51. T.A. Fulga, I. Elson-Schwab, V. Khurana, M.L. Steinhilb, T.L. Spires, and B.T. Hyman Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo Nat Cell Biol 9 2007 139 148
52. J.F. Zmuda, and R.J. Rivas Actin disruption alters the localization of tau in the growth cones of cerebellar granule neurons J Cell Sci 113 Pt 15 2000 2797 2809
53. A. Ebneth, R. Godemann, K. Stamer, S. Illenberger, B. Trinczek, and E. Mandelkow Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease J Cell Biol 143 1998 777 794
54. M. Tsukane, C. Yoshizaki, and T. Yamauchi Development and specific induction of apoptosis of cultured cell models overexpressing human tau during neural differentiation: implication in Alzheimer's disease Anal Biochem 360 2007 114 122
55. K. Sennvik, K. Boekhoorn, R. Lasrado, D. Terwel, S. Verhaeghe, and H. Korr Tau-4R suppresses proliferation and promotes neuronal differentiation in the hippocampus of tau knockin/knockout mice FASEB J 21 2007 2149 2161
56. S. Souter, and G. Lee Tubulin-independent tau in Alzheimer's disease and cancer: implications for disease pathogenesis and treatment Curr Alzheimer Res 2010 [Epub ahead of print] PMID: 20678073
57. H. Ding, P.J. Dolan, and G.V. Johnson Histone deacetylase 6 interacts with the microtubule-associated protein tau J Neurochem 106 2008 2119 2130
58. M. Perez, I. Santa-Maria, E. Gomez de Barreda, X. Zhu, R. Cuadros, and J.R. Cabrero Tauan inhibitor of deacetylase HDAC6 function J Neurochem 109 2009 1756 1766
59. E. Kpke, Y.C. Tung, S. Shaikh, A.C. Alonso, K. Iqbal, and I. Grundke-Iqbal Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease J Biol Chem 268 1993 24374 24384
60. A.D.C. Alonso, B. Li, I. Grundke-Iqbal, and K. Iqbal Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity Proc Natl Acad Sci USA 103 2006 8864 8869
61. H. Ksiezak-Reding, W.K. Liu, and S.H. Yen Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments Brain Res 597 1992 209 219
62. J.P. Brion, C. Smith, A.M. Couck, J.M. Gallo, and B.H. Anderton Developmental changes in tau phosphorylation: fetal tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer's disease J Neurochem 61 1993 2071 2080
63. E.S. Matsuo, R.W. Shin, M.L. Billingsley, A. Van deVoorde, M. O'Connor, and J.Q. Trojanowski Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau Neuron 13 1994 989 1002
64. C. Bancher, C. Brunner, H. Lassmann, H. Budka, K. Jellinger, and G. Wiche Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease Brain Res 477 1989 90 99
65. K. Iqbal, I. Grundke-Iqbal, T. Zaidi, P.A. Merz, G.Y. Wen, and S.S. Shaikh Defective brain microtubule assembly in Alzheimer's disease Lancet 2 1986 421 426
66. D.P. Hanger, J.C. Betts, T.L. Loviny, W.P. Blackstock, and B.H. Anderton New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry J Neurochem 71 1998 2465 2476
67. D.P. Hanger, H.L. Byers, S. Wray, K.-Y. Leung, M.J. Saxton, and A. Seereeram Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis J Biol Chem 282 2007 23645 23654
68. M. Morishima-Kawashima, M. Hasegawa, K. Takio, M. Suzuki, H. Yoshida, and A. Watanabe Hyperphosphorylation of tau in PHF Neurobiol Aging 16 1995 365 371
69. K. Iqbal, A.D.C. Alonso, S. Chen, M.O. Chohan, E. El-Akkad, and C.-X. Gong Tau pathology in Alzheimer disease and other tauopathies Biochim Biophys Acta 1739 2005 198 210
70. G. Lee, S.T. Newman, D.L. Gard, H. Band, and G. Panchamoorthy Tau interacts with src-family non-receptor tyrosine kinases J Cell Sci 111 Pt 21 1998 3167 3177
71. F. Hernandez, E. Gomez de Barreda, A. Fuster-Matanzo, J.J. Lucas, and J. Avila GSK3: a possible link between beta amyloid peptide and tau protein Exp Neurol 223 2010 322 325
72. E. Gmez de Barreda, M. Prez, P. Gmez Ramos, J. de Cristobal, P. Martn-Maestro, and A. Morn Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits Neurobiol Dis 37 2010 622 629
73. R. Brandt, G. Lee, D.B. Teplow, D. Shalloway, and M. Abdel-Ghany Differential effect of phosphorylation and substrate modulation on tau's ability to promote microtubule growth and nucleation J Biol Chem 269 1994 11776 11782
74. G. Drewes, B. Trinczek, S. Illenberger, J. Biernat, G. Schmitt-Ulms, and H.E. Meyer Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262 J Biol Chem 270 1995 7679 7688
75. S.M. Jenkins, and G.V. Johnson Phosphorylation of microtubule-associated protein tau on Ser 262 by an embryonic 100 kDa protein kinase Brain Res 767 1997 305 313
76. A. Sengupta, M. Novak, I. Grundke-Iqbal, and K. Iqbal Regulation of phosphorylation of tau by cyclin-dependent kinase 5 and glycogen synthase kinase-3 at substrate level FEBS Lett 580 2006 5925 5933
77. A. Sengupta, Q. Wu, I. Grundke-Iqbal, K. Iqbal, and T.J. Singh Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5 Mol Cell Biochem 167 1997 99 105
78. T.J. Singh, J.Z. Wang, M. Novak, E. Kontzekova, I. Grundke-Iqbal, and K. Iqbal Calcium/calmodulin-dependent protein kinase II phosphorylates tau at Ser-262 but only partially inhibits its binding to microtubules FEBS Lett 387 1996 145 148
79. S.J. Liu, J.Y. Zhang, H.L. Li, Z.Y. Fang, Q. Wang, and H.M. Deng Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain J Biol Chem 279 2004 50078 50088
80. L. Sun, X. Wang, S. Liu, Q. Wang, J. Wang, and M. Bennecib Bilateral injection of isoproterenol into hippocampus induces Alzheimer-like hyperphosphorylation of tau and spatial memory deficit in rat FEBS Lett 579 2005 251 258
81. T. Vandebroek, D. Terwel, T. Vanhelmont, M. Gysemans, C. Van Haesendonck, and Y. Engelborghs Microtubule binding and clustering of human Tau-4R and Tau-P301L proteins isolated from yeast deficient in orthologues of glycogen synthase kinase-3beta or cdk5 J Biol Chem 281 2006 25388 25397
82. T. Vandebroek, T. Vanhelmont, D. Terwel, P. Borghgraef, K. Lemaire, and J. Snauwaert Identification and isolation of a hyperphosphorylated, conformationally changed intermediate of human protein tau expressed in yeast Biochemistry 44 2005 11466 11475
83. A.D.C. Alonso, A. Mederlyova, M. Novak, I. Grundke-Iqbal, and K. Iqbal Promotion of hyperphosphorylation by frontotemporal dementia tau mutations J Biol Chem 279 2004 34873 34881
84. F. Liu, K. Iqbal, I. Grundke-Iqbal, G.W. Hart, and C.-X. Gong O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease Proc Natl Acad Sci USA 101 2004 10804 10809
85. S.R. Ryoo, H.J. Cho, H.W. Lee, H.K. Jeong, C. Radnaabazar, and Y.S. Kim Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease J Neurochem 104 2008 1333 1344
86. G. Lee, R. Thangavel, V.M. Sharma, J.M. Litersky, K. Bhaskar, and S.M. Fang Phosphorylation of tau by fyn: implications for Alzheimer's disease J Neurosci 24 2004 2304 2312
87. M.A. Tremblay, C.M. Acker, and P. Davies Tau phosphorylated at tyrosine 394 is found in Alzheimer's disease tangles and can be a product of the Abl-related kinase, Arg J Alzheimers Dis 19 2010 721 733
88. D.O. Azorsa, R.H. Robeson, D. Frost, B. Meechoovet, G.R. Brautigam, and C. Dickey High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation BMC Genomics 11 2010 25
89. K. Iijima-Ando, L. Zhao, A. Gatt, C. Shenton, and K. Iijima A DNA damage-activated checkpoint kinase phosphorylates tau and enhances tau-induced neurodegeneration Hum Mol Genet 19 2010 1930 1938
90. C.X. Gong, I. Grundke-Iqbal, Z. Damuni, and K. Iqbal Dephosphorylation of microtubule-associated protein tau by protein phosphatase-1 and -2C and its implication in Alzheimer disease FEBS Lett 341 1994 94 98
91. J.Z. Wang, C.X. Gong, T. Zaidi, I. Grundke-Iqbal, and K. Iqbal Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B J Biol Chem 270 1995 4854 4860
92. W. Qian, J. Shi, X. Yin, K. Iqbal, I. Grundke-Iqbal, and C.-X. Gong PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta J Alzheimer's Dis 19 2010 1221 1229
93. N. Nayeem, F. Kerr, H. Naumann, J. Linehan, S. Lovestone, and S. Brandner Hyperphosphorylation of tau and neurofilaments and activation of CDK5 and ERK1/2 in PTEN-deficient cerebella Mol Cell Neurosci 34 2007 400 408
94. Y. Sonoda, H. Mukai, K. Matsuo, M. Takahashi, Y. Ono, and K. Maeda Accumulation of tumor-suppressor PTEN in Alzheimer neurofibrillary tangles Neurosci Lett 471 2010 20 24
95. M.A. Amorim, C. Guerra-Araiza, O. Pernia, E.S.E.F. da Cruz, and L.M. Garcia-Segura Progesterone regulates the phosphorylation of protein phosphatases in the brain J Neurosci Res 2010 2826 2832
96. J. Bertrand, P. Senechal, M. Zummo-Soucy, V. Plouffe, and N. Leclerc The formation of tau pathological phospho-epitopes in the axon is prevented by the dephosphorylation of selective sites in primary hippocampal neurons over-expressing human tau J Neurochem 114 2010 1353 1367
97. F. Liu, I. Grundke-Iqbal, K. Iqbal, and C.-X. Gong Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation Eur J Neurosci 22 2005 1942 1950
98. C.X. Gong, T. Lidsky, J. Wegiel, L. Zuck, I. Grundke-Iqbal, and K. Iqbal Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease J Biol Chem 275 2000 5535 5544
99. E. Sontag, V. Nunbhakdi-Craig, G. Lee, R. Brandt, C. Kamibayashi, and J. Kuret Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies J Biol Chem 274 1999 25490 25498
100. M. Bennecib, C.X. Gong, I. Grundke-Iqbal, and K. Iqbal Inhibition of PP-2A upregulates CaMKII in rat forebrain and induces hyperphosphorylation of tau at Ser 262/356 FEBS Lett 490 2001 15 22
101. C.X. Gong, T.J. Singh, I. Grundke-Iqbal, and K. Iqbal Phosphoprotein phosphatase activities in Alzheimer disease brain J Neurochem 61 1993 921 927
102. S.E. Merrick, J.Q. Trojanowski, and V.M. Lee Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons J Neurosci 17 1997 5726 5737
103. E. Sontag, V. Nunbhakdi-Craig, G. Lee, G.S. Bloom, and M.C. Mumby Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A Neuron 17 1996 1201 1207
104. L. Li, A. Sengupta, N. Haque, I. Grundke-Iqbal, and K. Iqbal Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration FEBS Lett 566 2004 261 269
105. S. Kins, P. Kurosinski, R.M. Nitsch, and J. Gtz Activation of the ERK and JNK signaling pathways caused by neuron-specific inhibition of PP2A in transgenic mice Am J Pathol 163 2003 833 843
106. J.-J. Pei, C.-X. Gong, W.-L. An, B. Winblad, R.F. Cowburn, and I. Grundke-Iqbal Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease Am J Pathol 163 2003 845 858
107. A.C. Alonso, T. Zaidi, I. Grundke-Iqbal, and K. Iqbal Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease Proc Natl Acad Sci USA 91 1994 5562 5566
108. A.D. Alonso, I. Grundke-Iqbal, H.S. Barra, and K. Iqbal Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau Proc Natl Acad Sci USA 94 1997 298 303
109. A.C. Alonso, I. Grundke-Iqbal, and K. Iqbal Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules Nat Med 2 1996 783 787
110. B. Li, M.O. Chohan, I. Grundke-Iqbal, and K. Iqbal Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau Acta Neuropathol 113 2007 501 511
111. A. Alonso, T. Zaidi, M. Novak, I. Grundke-Iqbal, and K. Iqbal Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments Proc Natl Acad Sci USA 98 2001 6923 6928
112. C.M. Cowan, T. Bossing, A. Page, D. Shepherd, and A. Mudher Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo Acta Neuropathol 120 2010 593 604
113. R. Brandt, A. Gergou, I. Wacker, T. Fath, and H. Hutter A Caenorhabditis elegans model of tau hyperphosphorylation: induction of developmental defects by transgenic overexpression of Alzheimer's disease-like modified tau Neurobiol Aging 30 2009 22 33
114. M.L. Steinhilb, D. Dias-Santagata, E.E. Mulkearns, J.M. Shulman, J. Biernat, and E.-M. Mandelkow S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila J Neurosci Res 85 2007 1271 1278
115. O. Blard, S. Feuillette, J. Bou, B. Chaumette, T. Frbourg, and D. Campion Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in Drosophila Hum Mol Genet 16 2007 555 566
116. F. Liu, T. Zaidi, K. Iqbal, I. Grundke-Iqbal, R.K. Merkle, and C.X. Gong Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease FEBS Lett 512 2002 101 106
117. J.Z. Wang, I. Grundke-Iqbal, and K. Iqbal Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease Nat Med 2 1996 871 875
118. C.S. Arnold, G.V. Johnson, R.N. Cole, D.L. Dong, M. Lee, and G.W. Hart The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine J Biol Chem 271 1996 28741 28744
119. C.R. Torres, and G.W. Hart Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc J Biol Chem 259 1984 3308 3317
120. K. Kamemura, B.K. Hayes, F.I. Comer, and G.W. Hart Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation/phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens J Biol Chem 277 2002 19229 19235
121. C. Bancher, I. Grundke-Iqbal, K. Iqbal, V.A. Fried, H.T. Smith, and H.M. Wisniewski Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease Brain Res 539 1991 11 18
122. K. Iqbal, and I. Grundke-Iqbal Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease Mol Neurobiol 5 1991 399 410
123. M. Morishima, and Y. Ihara Posttranslational modifications of tau in paired helical filaments Dementia (Basel, Switzerland) 5 1994 282 288
124. M. Morishima-Kawashima, M. Hasegawa, K. Takio, M. Suzuki, K. Titani, and Y. Ihara Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments Neuron 10 1993 1151 1160
125. G. Mnch, W. Deuther-Conrad, and J. Gasic-Milenkovic Glycoxidative stress creates a vicious cycle of neurodegeneration in Alzheimer's diseasea target for neuroprotective treatment strategies? J Neural Transm Suppl 2002 303 307
126. T.C. Gamblin, F. Chen, A. Zambrano, A. Abraha, S. Lagalwar, and A.L. Guillozet Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease Proc Natl Acad Sci USA 100 2003 10032 10037
127. M. Novak, R. Jakes, P.C. Edwards, C. Milstein, and C.M. Wischik Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51 Proc Natl Acad Sci USA 88 1991 5837 5841
128. L. Fasulo, G. Ugolini, M. Visintin, A. Bradbury, C. Brancolini, and V. Verzillo The neuronal microtubule-associated protein tau is a substrate for caspase-3 and an effector of apoptosis J Neurochem 75 2000 624 633
129. A. de Calignon, L.M. Fox, R. Pitstick, G.A. Carlson, B.J. Bacskai, and T.L. Spires-Jones Caspase activation precedes and leads to tangles Nature 464 2010 1201 1204
130. J. Tucholski, J. Kuret, and G.V. Johnson Tau is modified by tissue transglutaminase in situ: possible functional and metabolic effects of polyamination J Neurochem 73 1999 1871 1880
131. S.M. Dudek, and G.V. Johnson Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau J Neurochem 61 1993 1159 1162
132. M.L. Miller, and G.V. Johnson Transglutaminase cross-linking of the tau protein J Neurochem 65 1995 1760 1770
133. M.A. Norlund, J.M. Lee, G.M. Zainelli, and N.A. Muma Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease Brain Res 851 1999 154 163
134. T. Horiguchi, K. Uryu, B.I. Giasson, H. Ischiropoulos, R. LightFoot, and C. Bellmann Nitration of tau protein is linked to neurodegeneration in tauopathies Am J Pathol 163 2003 1021 1031
135. P.I. Moreira, K. Honda, Q. Liu, M.S. Santos, C.R. Oliveira, and G. Aliev Oxidative stress: the old enemy in Alzheimer's disease pathophysiology Curr Alzheimer Res 2 2005 403 408 (Pubitemid 41277754)
136. A. Takeda, M.A. Smith, J. Avil, A. Nunomura, S.L. Siedlak, and X. Zhu In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification J Neurochem 75 2000 1234 1241
137. M. Hasegawa, M.J. Smith, and M. Goedert Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly FEBS Lett 437 1998 207 210
138. M. Hong, V. Zhukareva, V. Vogelsberg-Ragaglia, Z. Wszolek, L. Reed, and B.I. Miller Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17 Science (New York, NY) 282 1998 1914 1917
139. T.C. Gamblin, M.E. King, J. Kuret, R.W. Berry, and L.I. Binder Oxidative regulation of fatty acid-induced tau polymerization Biochemistry 39 2000 14203 14210
140. M. Goedert, M.G. Spillantini, R.A. Crowther, S.G. Chen, P. Parchi, and M. Tabaton Tau gene mutation in familial progressive subcortical gliosis Nat Med 5 1999 454 457
141. M. Hutton, C.L. Lendon, P. Rizzu, M. Baker, S. Froelich, and H. Houlden Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17 Nature 393 1998 702 705
142. M.G. Spillantini, J.R. Murrell, M. Goedert, M.R. Farlow, A. Klug, and B. Ghetti Mutation in the tau gene in familial multiple system tauopathy with presenile dementia Proc Natl Acad Sci USA 95 1998 7737 7741
143. D. Panda, J.C. Samuel, M. Massie, S.C. Feinstein, and L. Wilson Differential regulation of microtubule dynamics by three- and four-repeat tau: implications for the onset of neurodegenerative disease Proc Natl Acad Sci USA 100 2003 9548 9553
144. S.C. Feinstein, and L. Wilson Inability of tau to properly regulate neuronal microtubule dynamics: a loss-of-function mechanism by which tau might mediate neuronal cell death Biochim Biophys Acta 1739 2005 268 279
145. S.F. Levy, A.C. Leboeuf, M.R. Massie, M.A. Jordan, L. Wilson, and S.C. Feinstein Three- and four-repeat tau regulate the dynamic instability of two distinct microtubule subpopulations in qualitatively different manners. Implications for neurodegeneration J Biol Chem 280 2005 13520 13528
146. M. DeTure, L.-W. Ko, C. Easson, and S.-H. Yen Tau assembly in inducible transfectants expressing wild-type or FTDP-17 tau Am J Pathol 161 2002 1711 1722
147. L.-W. Ko, M. DeTure, N. Sahara, R. Chihab, I.E. Vega, and S.-H. Yen Recent advances in experimental modeling of the assembly of tau filaments Biochim Biophys Acta 1739 2005 125 139
148. T.G. Mack, R. Dayanandan, M. Van Slegtenhorst, A. Whone, M. Hutton, and S. Lovestone Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cells Neuroscience 108 2001 701 712
149. N. Matsumura, T. Yamazaki, and Y. Ihara Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) Am J Pathol 154 1999 1649 1656
150. M. Prez, J.M. Valpuesta, M. Medina, E. Montejo de Garcini, and J. Avila Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction J Neurochem 67 1996 1183 1190
151. Y. Tatebayashi, T. Miyasaka, D.-H. Chui, T. Akagi, K.-I. Mishima, and K. Iwasaki Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau Proc Natl Acad Sci USA 99 2002 13896 13901
152. C.W. Wittmann, M.F. Wszolek, J.M. Shulman, P.M. Salvaterra, J. Lewis, and M. Hutton Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles Science (New York, NY) 293 2001 711 714
153. J. Gtz, F. Chen, J. van Dorpe, and R.M. Nitsch Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils Science (New York, NY) 293 2001 1491 1495
154. L. Ho, Z. Xiang, P. Mukherjee, W. Zhang, N. De Jesus, and M. Mirjany Gene expression profiling of the tau mutant (P301L) transgenic mouse brain Neurosci Lett 310 2001 1 4
155. S.L. Lambourne, L.A. Sellers, T.G. Bush, S.K. Choudhury, P.C. Emson, and Y.-H. Suh Increased tau phosphorylation on mitogen-activated protein kinase consensus sites and cognitive decline in transgenic models for Alzheimer's disease and FTDP-17: evidence for distinct molecular processes underlying tau abnormalities Mol Cell Biol 25 2005 278 293
156. J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, and M. Van Slegtenhorst Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein Nat Genet 25 2000 402 405
157. K. Tanemura, T. Akagi, M. Murayama, N. Kikuchi, O. Murayama, and T. Hashikawa Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau Neurobiol Dis 8 2001 1036 1045
158. R.A. Crowther, and M. Goedert Abnormal tau-containing filaments in neurodegenerative diseases J Struct Biol 130 2000 271 279
159. M. Goedert, R. Jakes, M.G. Spillantini, M. Hasegawa, M.J. Smith, and R.A. Crowther Assembly of microtubule-associated protein tau into Alzheimer-like
160. E. Montejo de Garcini, J.C. Dez, and J. Avila Quantitation and characterization of tau factor in porcine tissues Biochim Biophys Acta 881 1986 456 461
161. I. Santa-Mara, F. Hernndez, C.P. Martn, J. Avila, and F.J. Moreno Quinones facilitate the self-assembly of the phosphorylated tubulin binding region of tau into fibrillar polymers Biochemistry 43 2004 2888 2897
162. D.M. Wilson, and L.I. Binder Polymerization of microtubule-associated protein tau under near-physiological conditions J Biol Chem 270 1995 24306 24314
163. H. Yanagawa, S.H. Chung, Y. Ogawa, K. Sato, T. Shibata-Seki, and J. Masai Protein anatomy: C-tail region of human tau protein as a crucial structural element in Alzheimer's paired helical filament formation in vitro Biochemistry 37 1998 1979 1988
164. I. Santa-Mara, M.A. Smith, G. Perry, F. Hernndez, J. Avila, and F.J. Moreno Effect of quinones on microtubule polymerization: a link between oxidative stress and cytoskeletal alterations in Alzheimer's disease Biochim Biophys Acta 1740 2005 472 480
165. S. Khatoon, I. Grundke-Iqbal, and K. Iqbal Guanosine triphosphate binding to beta-subunit of tubulin in Alzheimer's disease brain: role of microtubule-associated protein tau J Neurochem 64 1995 777 787
166. V.H. Mah, T.A. Eskin, A.M. Kazee, L. Lapham, and G.A. Higgins In situ hybridization of calcium/calmodulin dependent protein kinase II and tau mRNAs; species differences and relative preservation in Alzheimer's disease Brain Res Mol Brain Res 12 1992 85 94
167. S. Khatoon, I. Grundke-Iqbal, and K. Iqbal Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radioimmuno-slot-blot assay for nanograms of the protein J Neurochem 59 1992 750 753
168. K. Spittaels, C. Van den Haute, J. Van Dorpe, K. Bruynseels, K. Vandezande, and I. Laenen Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein Am J Pathol 155 1999 2153 2165
169. C.L. Weaver, M. Espinoza, Y. Kress, and P. Davies Conformational change as one of the earliest alterations of tau in Alzheimer's disease Neurobiol Aging 21 2000 719 727
170. G.A. Jicha, E. Lane, I. Vincent, L. Otvos, R. Hoffmann, and P. Davies A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease J Neurochem 69 1997 2087 2095
171. J.-Z. Wang, I. Grundke-Iqbal, and K. Iqbal Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration Eur J Neurosci 25 2007 59 68
172. R.A. Crowther, O.F. Olesen, R. Jakes, and M. Goedert The microtubule binding repeats of tau protein assemble into filaments like those found in Alzheimer's disease FEBS Lett 309 1992 199 202
173. T.C. Gamblin, R.W. Berry, and L.I. Binder Tau polymerization: role of the amino terminus Biochemistry 42 2003 2252 2257
174. M.D. Mukrasch, J. Biernat, M. von Bergen, C. Griesinger, E. Mandelkow, and M. Zweckstetter Sites of tau important for aggregation populate {beta}-structure and bind to microtubules and polyanions J Biol Chem 280 2005 24978 24986
175. M. Prez, M. Arrasate, E. Montejo De Garcini, V. Muoz, and J. Avila In vitro assembly of tau protein: mapping the regions involved in filament formation Biochemistry 40 2001 5983 5991
176. M. von Bergen, P. Friedhoff, J. Biernat, J. Heberle, E.M. Mandelkow, and E. Mandelkow Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure Proc Natl Acad Sci USA 97 2000 5129 5134
177. V. Khurana, and M.B. Feany Connecting cell-cycle activation to neurodegeneration in Drosophila Biochim Biophys Acta 1772 2007 446 456
178. V. Khurana, Y. Lu, M.L. Steinhilb, S. Oldham, J.M. Shulman, and M.B. Feany TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model Curr Biol 16 2006 230 241
179. D. Dias-Santagata, T.A. Fulga, A. Duttaroy, and M.B. Feany Oxidative stress mediates tau-induced neurodegeneration in Drosophila J Clin Investig 117 2007 236 245
180. A. Harada, K. Oguchi, S. Okabe, J. Kuno, S. Terada, and T. Ohshima Altered microtubule organization in small-calibre axons of mice lacking tau protein Nature 369 1994 488 491
181. S. Ikegami, A. Harada, and N. Hirokawa Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice Neurosci Lett 279 2000 129 132
182. Y. Takei, J. Teng, A. Harada, and N. Hirokawa Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b genes J Cell Biol 150 2000 989 1000
183. T. Engel, P. Goni-Oliver, J.J. Lucas, J. Avila, and F. Hernandez Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert J Neurochem 99 2006 1445 1455
184. F. Hernndez, J.D. Nido, J. Avila, and N. Villanueva GSK3 inhibitors and disease Mini Rev Med Chem 9 2009 1024 1029
185. M. Bols, S. Fernandez, and I. Torres-Aleman Oral administration of a GSK3 inhibitor increases brain insulin-like growth factor I levels J Biol Chem 285 2010 17693 17700
186. R.S. Jope, C.J. Yuskaitis, and E. Beurel Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics Neurochem Res 32 2007 577 595
187. M. Kitazawa, S. Oddo, T.R. Yamasaki, K.N. Green, and F.M. LaFerla Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease J Neurosci 25 2005 8843 8853
188. Y. Wen, E. Planel, M. Herman, H.Y. Figueroa, L. Wang, and L. Liu Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing J Neurosci 28 2008 2624 2632
189. S. Le Corre, H.W. Klafki, N. Plesnila, G. Hbinger, A. Obermeier, and H. Sahagn An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice Proc Natl Acad Sci USA 103 2006 9673 9678
190. M. Li, A. Makkinje, and Z. Damuni The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A J Biol Chem 271 1996 11059 11062
191. M. Li, A. Makkinje, and Z. Damuni Molecular identification of I1PP2A, a novel potent heat-stable inhibitor protein of protein phosphatase 2A Biochemistry 35 1996 6998 7002
192. L. Petrucelli, D. Dickson, K. Kehoe, J. Taylor, H. Snyder, and A. Grover CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation Hum Mol Genet 13 2004 703 714
193. M. Deture, C. Hicks, and L. Petrucelli Targeting heat shock proteins in tauopathies Curr Alzheimer Res 2010 [Epub ahead of print] PMID: 20678072
194. J.Q. Trojanowski, A.B. Smith, D. Huryn, and V.M.Y. Lee Microtubule-stabilising drugs for therapy of Alzheimer's disease and other neurodegenerative disorders with axonal transport impairments Expert Opin Pharmacother 6 2005 683 686
195. N. Shiryaev, Y. Jouroukhin, E. Giladi, E. Polyzoidou, N.C. Grigoriadis, and H. Rosenmann NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model Neurobiol Dis 34 2009 381 388
196. C. Alonso Adel, and C.P. Corbo Novel therapeutics based on tau/microtubule dynamics: WO2008084483 Expert Opin Ther Pat 19 2009 1335 1338
197. X. Xu, K.W. Chua, C.C. Chua, C.F. Liu, R.C. Hamdy, and B.H. Chua Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury Brain Res 1355 2010 189 194
198. W. Zhang, J. Miao, J. Hao, Z. Li, J. Xu, and R. Liu Protective effect of S14G-humanin against beta-amyloid induced LTP inhibition in mouse hippocampal slices Peptides 30 2009 1197 1202
199. I. Gozes, A. Stewart, B. Morimoto, A. Fox, K. Sutherland, and D. Schmeche Addressing Alzheimer's disease tangles: from NAP to AL-108 Curr Alzheimer Res 6 2009 455 460
200. I. Gozes, and I. Divinski NAP, a neuroprotective drug candidate in clinical trials, stimulates microtubule assembly in the living cell Curr Alzheimer Res 4 2007 507 509
201. R. Bhattacharya, and F. Cabral A ubiquitous beta-tubulin disrupts microtubule assembly and inhibits cell proliferation Mol Biol Cell 15 2004 3123 3131
202. K. Santacruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, and M. Ingelsson Tau suppression in a neurodegenerative mouse model improves memory function Science (New York, NY) 309 2005 476 481
203. C. Andorfer, C.M. Acker, Y. Kress, P.R. Hof, K. Duff, and P. Davies Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms J Neurosci 25 2005 5446 5454
204. W. Bondareff, C.Q. Mountjoy, M. Roth, and D.L. Hauser Neurofibrillary degeneration and neuronal loss in Alzheimer's disease Neurobiol Aging 10 1989 709 715
205. A.D. Cash, G. Aliev, S.L. Siedlak, A. Nunomura, H. Fujioka, and X. Zhu Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation Am J Pathol 162 2003 1623 1627
206. M. Arrasate, S. Mitra, E.S. Schweitzer, M.R. Segal, and S. Finkbeiner Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death Nature 431 2004 805 810
207. K. Iqbal, A.C. Alonso, C.X. Gong, S. Khatoon, T.J. Singh, and I. Grundke-Iqbal Mechanism of neurofibrillary degeneration in Alzheimer's disease Mol Neurobiol 9 1994 119 123
208. P. Cras, M.A. Smith, P.L. Richey, S.L. Siedlak, P. Mulvihill, and G. Perry Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease Acta Neuropathol 89 1995 291 295
209. I. Khlistunova, J. Biernat, Y. Wang, M. Pickhardt, M. von Bergen, and Z. Gazova Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs J Biol Chem 281 2006 1205 1214
210. A. Takashima Tau Aggregation is a Therapeutic Target for Alzheimer's Disease Curr Alzheimer Res 2010 [Epub ahead of print] PMID: 20678070
211. M. Boimel, N. Grigoriadis, A. Lourbopoulos, E. Haber, O. Abramsky, and H. Rosenmann Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice Exp Neurol 224 2010 472 485
212. E.M. Sigurdsson Tau-focused immunotherapy for Alzheimer's disease and related tauopathies Curr Alzheimer Res 6 2009 446 450
213. G.G. Glenner, and C.W. Wong Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein Biochem Biophys Res Commun 120 1984 885 890
214. I. Grundke-Iqbal, K. Iqbal, M. Quinlan, Y.C. Tung, M.S. Zaidi, and H.M. Wisniewski Microtubule-associated protein tau. A component of Alzheimer paired helical filaments J Biol Chem 261 1986 6084 6089